FREE subscriptions for doctors and students... click here
You have 3 more open access pages.
Stroke or TIA in patients with non rheumatic atrial fibrilation in whom intracranial
haemorrhage has been excluded should be given aspirin:
- in NRAF aspirin prevents 40 vascular events per 1000 patient years of treatment
- definitive anti-platelet therapy should be commenced at 2 weeks post symptoms
Anticoagulation should be introduced subsequently:
- in NRAF anticoagulation prevents 90 vascular events per 1000 patient years
of treatment (1).
- (1) European Atrial Fibrillation Trial Study Group. Secondary prevention
in non-rheumatic atrial fibrillation after transient ischaemic attack or minor
stroke. Lancet, 1993;342: 1255.
Last edited 04/2020